Key facts
- This page summarizes Wei Peu Zen's Form 4 filing for Emmaus Life Sciences, Inc. (EMMA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Dec 2023, 19:40.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Other
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Other
Additional SEC filing notes
Footnote F1
The shares shown were issued in exchange for principal and accrued interest under the promissory note of the Issuer held by the reporting person referred to in footnote (2), below, which promissory note was surrendered by the reporting person for cancellation.
Footnote F2
Profit Preview International Group Limited is a Hong Kong limited company wholly owned by the Reporting Person and of which the Reporting Person is a director.
Footnote F3
The Convertible Promissory Note dated 2023-01-18 was surrendered to the Issuer for cancellation in exchange for the shares referred to in footnote (1), above.
Footnote F4
Represent shares previously issuable upon conversion of the Convertible Promissory Note.